This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1973 May;4(3):21-6.

Nitrosoureas in central nervous system tumors

PMID: 4584033

Review

Nitrosoureas in central nervous system tumors

M D Walker. Cancer Chemother Rep 3. 1973 May.

. 1973 May;4(3):21-6.

Author

PMID: 4584033

No abstract available

PubMed Disclaimer

Similar articles

Formulation of three nitrosoureas for intravenous use.
Davignon JP, Yang KW, Wood HB Jr, Cradock JC. Davignon JP, et al. Cancer Chemother Rep 3. 1973 May;4(3):7-11. Cancer Chemother Rep 3. 1973. PMID: 4201309 No abstract available.
Treatment of brain tumors with 1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
Takeuchi J, Nakao S, Handa H. Takeuchi J, et al. Nihon Geka Hokan. 1973 Apr;42(2):184-9. Nihon Geka Hokan. 1973. PMID: 4738478 No abstract available.
[Value of chemotherapy associated with conventional treatment of malignant gliomas of the brain. Study of 95 cases with histological verification and follow-up of 1 to 6 years 9 months].
Paillas JE, Prince MA, Hassoun J, Pellet W, Peragut JC. Paillas JE, et al. Rev Neurol (Paris). 1979 Mar;135(3):251-62. Rev Neurol (Paris). 1979. PMID: 227020 French. No abstract available.
[Clinical significance of mustoforan in management of malignant glioma].
Kobiakov GL. Kobiakov GL. Vopr Onkol. 2007;53(6):724-9. Vopr Onkol. 2007. PMID: 18416147 Review. Russian. No abstract available.
An overview of the status of the nitrosoureas in other tumors.
Carter SK. Carter SK. Cancer Chemother Rep 3. 1973 May;4(3):35-46. Cancer Chemother Rep 3. 1973. PMID: 4584034 Review. No abstract available.

See all similar articles

Cited by

Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice.
Fisher RI, Mandell GL, Bostick F, McMenamin MG, Anderson T. Fisher RI, et al. Clin Exp Immunol. 1980 Feb;39(2):416-25. Clin Exp Immunol. 1980. PMID: 6446427 Free PMC article.
Chemosensitivity testing of human gliomas using a fluorescent microcarrier technique.
Bowles AP Jr, Pantazis CG, Wansley W, Allen MB. Bowles AP Jr, et al. J Neurooncol. 1990 Apr;8(2):103-12. doi: 10.1007/BF00177832. J Neurooncol. 1990. PMID: 2358844
Brain tumor chemotherapy using a rat glioma model.
Tamura M, Mennel HD, Zülch KJ. Tamura M, et al. J Cancer Res Clin Oncol. 1979 May 14;94(1):39-46. doi: 10.1007/BF00405348. J Cancer Res Clin Oncol. 1979. PMID: 468898
Antineoplastic drugs in 1990. A review (Part II).
Black DJ, Livingston RB. Black DJ, et al. Drugs. 1990 May;39(5):652-73. doi: 10.2165/00003495-199039050-00003. Drugs. 1990. PMID: 2191847 Review. No abstract available.
Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds.
Paoletti P, Robustelli della Cuna G, Knerich R, Strada MR. Paoletti P, et al. Acta Neurochir (Wien). 1978;41(4):287-99. doi: 10.1007/BF01811342. Acta Neurochir (Wien). 1978. PMID: 356524 Clinical Trial.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database